This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various biologically active molecules. Its structure is particularly valuable in the development of kinase inhibitors, which are crucial in targeted cancer therapies. Researchers leverage its pyrido[3,4-d]pyrimidin-4(3H)-one core to design compounds that can selectively inhibit specific kinases involved in cell proliferation and survival. Additionally, its fluorine substitution enhances the compound's binding affinity and metabolic stability, making it a promising candidate for drug discovery efforts. It is also explored in the development of treatments for inflammatory diseases and neurological disorders due to its potential to modulate specific enzymatic pathways.